203 related articles for article (PubMed ID: 25703650)
1. Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver?
Duran R; Ronot M; Di Renzo S; Gregoli B; Van Beers BE; Vilgrain V
Eur J Radiol; 2015 May; 84(5):816-22. PubMed ID: 25703650
[TBL] [Abstract][Full Text] [Related]
2. Hepatic hemangiomas: factors associated with T2 shine-through effect on diffusion-weighted MR sequences.
Duran R; Ronot M; Kerbaol A; Van Beers B; Vilgrain V
Eur J Radiol; 2014 Mar; 83(3):468-78. PubMed ID: 24364922
[TBL] [Abstract][Full Text] [Related]
3. MR features of small hepatocellular carcinoma in normal, fibrotic, and cirrhotic livers: a comparative study.
Sheng RF; Zeng MS; Ji Y; Yang L; Chen CZ; Rao SX
Abdom Imaging; 2015 Oct; 40(8):3062-9. PubMed ID: 26329976
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
[TBL] [Abstract][Full Text] [Related]
5. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
[TBL] [Abstract][Full Text] [Related]
6. Hemangioma in the cirrhotic liver: diagnosis and natural history.
Brancatelli G; Federle MP; Blachar A; Grazioli L
Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
8. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
9. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
[TBL] [Abstract][Full Text] [Related]
10. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.
Tokgoz O; Unlu E; Unal I; Serifoglu I; Oz I; Aktas E; Caglar E
Afr Health Sci; 2016 Mar; 16(1):227-33. PubMed ID: 27358636
[TBL] [Abstract][Full Text] [Related]
13. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
14. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.
Bennett GL; Petersein A; Mayo-Smith WW; Hahn PF; Schima W; Saini S
AJR Am J Roentgenol; 2000 Feb; 174(2):477-85. PubMed ID: 10658728
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
Wang H; Wang XY; Jiang XX; Ye ZX
Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
[TBL] [Abstract][Full Text] [Related]
16. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
17. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
[TBL] [Abstract][Full Text] [Related]
18. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
19. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
20. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
